Skip to Content

Tag: Ascensia Diabetes Care


News

In brief: OCR investigation, NHIA recommendations, SuperCare pilot

March 15, 2024HME News Staff

WASHINGTON – The Office of Civil Rights, which administers and enforces HIPAA private, security and breach notification rules, has announced that it will investigate the cyberattack on Change Healthcare to determine whether patient health information was compromised.  The agency will also investigate whether Change Healthcare and UnitedHealth Group were compliant with HIPAA rules.  “We are committed to ensuring access to care, while enforcing laws that bolster patient...

Ascensia Diabetes Care, Change Healthcare, Cyberattack, National Home Infusion Association (NHIA), SuperCare Health


Read Full Articlered right arrow icon

Also Noted

Ascensia extends PASS program

March 14, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings will extend the Eversense Payment Assistance and Simple Savings (PASS) Program. Designed to help people in the U.S. access the Eversense E3 CGM System more affordably, the program offers major savings for eligible individuals looking to experience the unique benefits of the only long-term CGM system available. Eligible individuals will pay only $99 out of pocket for an unlimited number of six-month Eversense E3 systems under...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Diabetes, Eversense, Senseonics


Read Full Articlered right arrow icon

Also Noted

Ascensia announces coverage expansion for CGM system 

February 12, 2024HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of local coverage determinations that provide access to implantable CGM for basal-only patients. Medicare coverage has been expanded for implantable CGMs to include all people with diabetes using insulin, removing the previous requirement for multiple inulin administrations per day. Coverage has also been updated...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Eversense, Senseonics


Read Full Articlered right arrow icon

Also Noted

Ascensia names leader for CGM business 

February 6, 2024HME News Staff

TOKYO – PHC Holdings Corp., the parent company of Ascensia Diabetes Care, and Senseonics Holdings have announced that diabetes industry veteran Brian Hansen has been appointed to the newly created role of president of CGM at Ascensia Diabetes Care effective today, Feb. 6, 2024. Hansen will be responsible for the global commercialization and growth of the Eversense CGM, which is currently available in the U.S. and select European markets. “Eversense is a game-changer for people with diabetes...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Eversense CGM, PHC Holdings, Senseonics


Read Full Articlered right arrow icon

Also Noted

Ascensia featured in film series

December 6, 2023HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care is participating in a new film series featuring the story of patient advocate and Eversense user Troy Ita. The “Connecting the Dots” series, which brings into focus the evolution of medical technologies, includes Ascensia’s mini-documentary style video focusing on Troy’s journey with diabetes and how the evolution in continuous glucose monitoring technology has supported him to live a fuller, less interrupted life. In particular,...

Ascensia Diabetes Care, Eversense CGM


Read Full Articlered right arrow icon

Also Noted

Ascensia, Senseonics launch ad campaign

October 11, 2023HME News Staff

PARSIPPANY, N.J., and GERMANTOWN, Md. – Ascensia Diabetes Care and Senseonics Holdings have launched a new U.S. advertising and marketing campaign for the Eversense E3 CGM System. The “CGM for Real Life” campaign seeks to drive awareness of the Eversense E3, a six-month, implantable sensor, as well as the everyday challenges people with diabetes face. “This campaign is designed to challenge the status quo in continuous glucose monitoring, which for too long has meant self-insertion...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Senseonics


Read Full Articlered right arrow icon

Ascensia: ‘This is Diabetes, This is Real’ 

Also Noted

Ascensia: ‘This is Diabetes, This is Real’ 

September 19, 2023HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care, owner of the CONTOUR blood glucose monitoring system portfolio and exclusive distributor of the Eversense continuous glucose monitoring system, has opened submissions for its art and photo competition in support of World Diabetes Day 2023. The theme of this year’s competition is “This is Diabetes, This is Real,” aiming to capture the challenges, successes and day-to-day realities of people living with diabetes. “For our 2023...

Ascensia Diabetes Care, Blood Glucose Monitor, Continuous Glucose Monitor (CGM), CONTOUR, Diabetes, Eversense, World Diabetes Day


Read Full Articlered right arrow icon

News

In brief: Humana MA contracts, Philips CFO, OSA-long COVID connection

May 12, 2023HME News Staff

LOUISVILLE, Ky. - Humana has announced agreements with AdaptHealth and Rotech Healthcare to provide home medical equipment services to its Humana Medicare Advantage HMO members.  The two national companies will begin providing services to these members under a value-based structure beginning July 1, with each serving a specific region of the country.  “Partnering with national DME partners under a value-based arrangement aligns with our goal to enhance access to the home care...

AdaptHealth, Ascensia Diabetes Care, Humana, Philips, Rotech Healthcare, Sleep Apnea


Read Full Articlered right arrow icon

Also Noted

Ascensia expands payment assistance program

May 10, 2023HME News Staff

PARSIPPANY, N.J. – Ascensia Diabetes Care, maker of the Contour Blood Glucose Monitoring (BGM) System portfolio and exclusive distributor of Eversense Continuous Glucose Monitoring (CGM) Systems, announces that it has significantly expanded Eversense PASS, a payment assistance and simple savings program designed to enhance affordability and access to the Eversense E3. Under the new and improved program, there will be more people with diabetes eligible for assistance paying for the system and...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), Diabetes, Eversense CGM


Read Full Articlered right arrow icon

Business Development

Key to diabetes market? Patient self-care

February 27, 2023John Andrews

Diabetes patients want to be empowered to gain more control over the management of their disease and that should be the top consideration for HME providers in charge of their care, specialists in the field say.  Elaine Anderson, head of the Eversense CGM Business Unit at Parsippany, N.J.-based Ascensia Diabetes Care, contends that patient choice is a significant driver in diabetes and other products in the medical supplies category.  “As we learn more about certain conditions...

Ascensia Diabetes Care, Continuous Glucose Monitor (CGM), DermaRite Industries, Diabetes, GEMCO Medical, Jodi RohlwingHettich


Read Full Articlered right arrow icon